Merck KGaA, Pfizer Receive Positive EMA Opinion for Orphan Drug Designation for Avelumab in Merkel Cell Carcinoma
November 25, 2015 at 04:12 AM EST
Merck KGaA (OTC: MGKAY) and Pfizer (NYSE: PFE) today announced that the European Medicines Agency (EMA)'s Committee ...